Kalshi· Science and Technology

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

Chance

92%

Buy Yes

95¢

pays $1 if it happens

Buy No

11¢

pays $1 if it doesn’t

Prices from Kalshi, updated 8 minutes ago. Ends Oct 1, 3:59 AM UTC.

Price over the last 2 weeks

Cost of a Yes share

How this market is decidedShow

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Oct 1, 2027, then the market resolves to Yes.